Atria Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-11,261
Closed -$1.25M 1262
2019
Q4
$1.25M Sell
11,261
-309
-3% -$31.8K 0.03% 459
2019
Q3
$1.15M Sell
11,570
-143
-1% -$14.2K 0.04% 372
2019
Q2
$1.11M Buy
11,713
+1,935
+20% +$185K 0.04% 384
2019
Q1
$1.08M Buy
9,778
+114
+1% +$11.9K 0.05% 332
2018
Q4
$889K Buy
9,664
+1,738
+22% +$176K 0.04% 335
2018
Q3
$873K Buy
+7,926
New +$825K 0.03% 434

Other funds holding PRAH

Atria Investments's PRAH Position: Q1 2020 in Review

Atria Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 11,261 shares — an estimated $1.25M sold.

Atria Investments first reported a position in PRAH in Q3 2018 and held it in 6 quarters. The position peaked at $1.25M in Q4 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Atria Investments reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Atria Investments sold 11,261 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $1.25M.
  • Atria Investments first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 6 quarters.
  • Atria Investments's PRA Health Sciences, Inc. position peaked at $1.25M in Q4 2019.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Atria Investments's 13F filing for Q1 2020, filed 15 May 2020.